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Recurrent Bilateral Giant Fibroadenomas  
of the Breasts
Ashley Morris, B.S., and Kitt Shaffer, M.D., Ph.D.
We present a case of an 18-year-old woman with recurrent bilateral giant fibroadenomas that were eval-
uated by mammography and sonography with color Doppler. Imaging revealed solid lobulated masses 
with significant internal vascularity occupying most of each breast; this evaluation suggested a differ-
ential diagnosis of giant fibroadenoma versus phyllodes tumor. The unusual clinical story of recurrent 
bilateral lesions as reported by the patient, coupled with the findings on visualization of these lesions by 
mammography and ultrasound with color Doppler, led to the clinical decision to forego biopsy in favor 
of immediate bilateral surgical enucleation.
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 An 18-year-old female from Haiti presented to the 
Cambridge Hospital Breast Center with a chief complaint 
of bilateral painful, swollen breasts for the past 1.5 years. 
On further history she explained that she had originally 
experienced a burning pain in both breasts exclusively 
around the time of menstruation but that this pain had 
since become constant. She remarked that the increased 
frequency of the pain correlated with a marked gradual in-
crease in size of both breasts over the course of the past two 
years. She denied any change in breast size with menses, 
any nipple discharge, or any constitutional symptoms. The 
patient did note that she had similar “lumps” surgically re-
moved from both breasts approximately 2.5 years prior to 
this current presentation, at the age of 16, while still living 
in Haiti; she reported that at the time of the prior surgery 
she was informed that the lumps were cysts. She stated that 
subsequent to the previous surgery her breast size was sig-
 The term “giant fibroadenoma” is a descriptive name giv-
en to a fibroadenoma that is greater than 5cm in diameter 
or weighs more than 500g [1]. These rare benign tumors 
most commonly affect females of Afro-Caribbean or East 
Asian descent and have a bimodal age distribution with 
occurrence typically either in adolescent or premenopausal 
women [2]. Giant fibroadenomas can be variants of either 
adult type fibroadenomas or the less common juvenile 
fibroadenoma, both of which are benign circumscribed 
breast masses resulting from proliferation of stromal and 
epithelial (glandular) tissue [3]. In this report, we present 
the case of recurrent bilateral giant fibroadenomas in an 
18-year-old female from Haiti. The subsequent discus-
sion addresses those features of this case that are typical of 
this diagnosis, as well as the unique aspects of this specific 
clinical presentation.
Introduction
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nificantly reduced but that her breasts soon began to grow 
again and that currently both were much larger than they 
had been at the time of the first procedure. She originally 
attributed this growth to normal development and only 
sought medical attention when the associated pain became 
unbearable.
 The patient was screened for known breast cancer risk 
factors. She reported menarche at age 12 without con-
sequent use of oral contraception and denied any preg-
nancies. The patient denied any alcohol use or previous 
radiation exposure. She was not taking any medications. 
Her only pertinent family history was a maternal great 
aunt who had breast cancer in her 50s.
 On physical exam at the Breast Center the patient was 
found to have visibly distorted breast contours bilaterally. 
On palpation, the right breast was found to be occupied 
by a large, irregular, hard protuberant mass that filled 
most of the breast. This was accompanied by overlying 
shiny, thinned skin with several prominent dilated veins, 
likely due to the proximity of the mass to the skin. The 
left breast was similarly occupied by a large, irregular, hard 
protuberant mass in the central region, smaller than on the 
right and without any overlying skin changes. The patient 
did not have any evidence of nipple abnormalities or axil-
lary lymphadenopathy.
 The patient was sent for bilateral mammograms and 
ultrasounds of the lesions, with concern of slow grow-
ing sarcoma or phyllodes tumor. Mammography showed 
highly suspicious large homogeneous lobulated masses 
Figure 1B. Mammographic mediolateral oblique images of 
the right and left breasts show large masses (black arrows). 
Skin markers are present at the white arrows, indicating 
palpable abnormalities.
occupying most of each breast. The lesion on the right was 
approximately 12 cm in diameter while that on the left was 
approximately 10 cm in diameter (Fig. 1). Neither mass 
appeared to extend to the pectoralis muscle and the there 
was no evidence of suspicious calcification in either breast.
 Breast sonography demonstrated fairly homogeneous 
hypoechoic solid lobulated masses occupying most of each 
breast, with internal vascularity demonstrated by color 
Doppler and increased through transmission (Figures 
2A-D). The imaging studies of the breasts were together 
classified as BI-RADS 5: highly suggestive of malignancy 
with indication for biopsy.
 Given the alarming history of the rapid recurrence 
of these tumors and the striking vascularity indicted by 
ultrasound of the lesions, it was decided that biopsy would 
not change the management of the patient’s case and 
could potentially introduce complications such as bruis-
ing, bleeding, infection or pain. Furthermore, neither 
fine-needle aspiration biopsy nor core needle biopsy has 
been found to be efficacious in the differentiation between 
phyllodes tumor and fibroadenomas. Rather, surgical 
intervention was indicated. The patient was taken to the 
operating room where she underwent bilateral enucleation 
of the breast masses (Fig. 3). The surgical specimens were 
sent to pathology where histologic examination concluded 
a diagnosis of benign giant fibroadenoma variants (Fig. 4).
 Fibroadenomas are the most common cause of a breast 
mass in young females, accounting for approximately 75% 
Figure 1A. 18-year-old woman with recurrent bilateral giant 
fibroadenomas. Mammographic craniocaudal views of both 
breasts show large, dense, homogeneous masses (black 
arrows) approximately 12 cm at its largest diameter on the 
right and 10 cm on the left. A skin marker noting the site of 
prior surgical scar is indicated by the white arrows.
Discussion
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of all breast lesions in young females [4]. However only 
0.5-2% of all cases of fibroadenomas can be classified as 
giant fibroadenomas [5]. Furthermore, the development 
of multiple fibroadenomas, as presented in this case, oc-
curs in only 15% of cases of giant fibroadenomas [6]. As 
a teenaged female of Afro-Caribbean descent, the patient 
depicted in this case represents the “classic” patient af-
flicted with this rare condition.
 Giant fibroadenomas typically present clinically with 
pain and breast enlargement. They are usually smooth, 
firm, nontender and mobile to palpation, and most often 
occur in the upper outer quadrant of the breast [7]. There 
may be overlying skin changes. Other potential causes 
of significant breast enlargement, or macromastia, which 
must be considered when evaluating a patient presenting 
with this complaint include juvenile hypertrophy, macro-
cyst, lipoma, hemangioma, pseudoangiomatous stromal 
hyperplasia, cystosarcoma phyllodes and fibroadenoma. 
A thorough history and physical exam, coupled with ap-
propriate imaging evaluation, allows for narrowing of the 
differential. Juvenile (benign virginal) hypertrophy is a 
rare condition caused by an abnormal response to estrogen 
resulting in tissue hypertrophy, either unilaterally or bilat-
erally. This condition is not associated with the presence of 
a definable mass lesion on physical or imaging evaluation 
[5]. Macrocysts may present with both pain and breast en-
largement, however on ultrasound these masses will appear 
as anechoic, fluid-filled lesions [8]. The mass lesion caused 
by a lipoma will be soft and is typically neither mobile 
nor discrete, while a large hemangioma would typically 
have associated cutaneous signs of vascular proliferation. 
Pseudoangiomatous stromal hyperplasia (PASH) is a rare 
condition which usually presents as small incidental foci 
or tumors in premenopausal women, rather than large 
nodular masses in young women, with only 4 documented 
cases of the latter presentation. Thus, while the categorical 
exclusion of PASH as a diagnosis requires histologic exami-
nation, it remains epidemiologically an extremely unlikely 
diagnosis [9]. Therefore despite the multiple diagnoses 
that must be considered with such a presentation, most 
diagnoses have specific clinical or imaging features that 
distinguish them. However, there is no such distinguish-
ing clinical or imaging feature that discriminates between 
cystosarcoma phyllodes and giant fibroadenoma, and thus 
determination of a final diagnosis is particularly challeng-
ing.
 The appearance of a giant fibroadenoma on mammog-
raphy is consistent with that of a benign fibroadenoma: 
a dense, sometimes lobulated, well-circumscribed mass 
with sharp margins. There may be a surrounding lucent 
halo. However, since giant fibroadenomas most commonly 
occur in pre-menopausal women, the pathognomonic 
“popcorn-like” calcifications that may be appreciated on 
mammographic imaging of fibroadenomas are rare in giant 
fibroadenomas, since this finding results from involution 
of the tumor in post-menopausal women [6].
 The mammographic findings in the presented case were 
designated BI-RADS 5, implying a likelihood of malig-
nancy greater than 95%. However, several features of the 
clinical presentation and imaging findings pointed to a 
benign process, suggesting that BI-RADS 4 might have be 
a more suitable designation. Specifically, the masses were 
smoothly marginated, bilateral, and occurred in an 18 year 
old individual. Even if such findings could not exclude the 
possibility of phyllodes tumors, the majority of phyllodes 
tumors are benign. Thus, categorizing these mammograph-
ic findings as BI-RADS 4, indicating a highly suspicious 
abnormality with a likelihood of malignancy between 23% 
and 34% [10], would have perhaps been more appropriate.
Figure 2A. Sonography of the right breast shows a large solid 
lobulated hypoechoic lesion occupying most of the breast. 
Color Doppler study of the right breast mass reveals signifi-
cant intralesional blood flow.
Figure 2B. Sonography of the left breast showing a large 
solid hypoechoic lesion, slightly larger than that on the right, 
occupying most of the breast. Color Doppler study of the 
left breast mass reveals significant intralesional blood flow, 
similar to that found in the right breast lesion.
 Breast ultrasound allows for discrimination of breast 
cysts, which are typically anechoic fluid-filled spheres, 
from solid tumors, which are typically hypoechoic [8]. 
Specifically, on ultrasonographic evaluation, fibroadenomas 
appear as well-circumscribed elliptical homogeneous mass-
es that are either hypo- or isoechoic, with smooth borders 
and posterior acoustic enhancement. They are typically 
larger in the transverse than the anteroposterior axis [6]. 
Ultrasound is particularly useful in evaluation of fibroad-
enomas since young women commonly have dense breast 
tissue, rendering mammography more difficult. While the 
presence on ultrasound of clefts or cysts in a well-defined 
solid mass is typical of a phyllodes tumor, this is not a 
pathognomonic findings and further diagnostic evaluation 
is mandatory. [11]
 MRI is currently emerging as a useful complement 
to the more established breast imaging modalities. On 
T2-weighted images of fibroadenomas, septations which 
demarcate the separation between lobules can be appreci-
ated. This pattern emerges because of the characteristic 
growth of fibroadenomas in adjacent lobules [5]. This 
feature alone, however, is not sufficient to distinguish be-
tween a phyllodes tumor and a giant fibroadenoma. Thus, 
even with the addition of MRI to the radiologic armamen-
tarium, imaging survey and clinical examination do not 
provide adequate information for the conclusive diagnosis 
of giant fibroadenoma.
 A giant fibroadenoma can be distinguished histologi-
cally from a phyllodes tumor by the lack of stromal atypia, 
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stromal overgrowth, stromal condensation surrounding 
ducts, and leaf-like architecture typical of a phyllodes 
tumor (Figure 4A, 4B) [12]. Rather, a giant fibroadenoma 
will have histology consistent with that of a fibroadenoma: 
a well-circumscribed proliferation of stromal and epi-
thelial tissue, which can be classified as pericanalicular, 
intracanalicular, or variant, referring to the location of the 
stromal proliferation. This subclassification is a histologic 
distinction and carries no prognostic value. The distinc-
tion between phyllodes tumor and giant fibroadenoma, 
however is prognostically significant: phyllodes tumors 
may be malignant while fibroadenomas are benign, with 
no association between the presence of a fibroadenoma 
and subsequent breast cancer development [13]. Though 
benign, because of their size giant fibroadenomas are none-
theless associated with significant morbidity, including 
venous congestion, glandular distortion, pressure necrosis, 
and occasionally ulceration [5, 14].
 Of note, there is a documented association between the 
use of cyclosporine A therapy in renal transplant recipients 
and the occurrence of multiple fibroadenomas. Specifically, 
several cases of multiple giant fibroadenomas in associa-
tion with cyclosporine A therapy have been reported. 
Possible mechanisms to account for this effect include 
direct effects of cyclosporine A on fibroblasts of the breast 
tissue, antagonism of prolactin receptor sites, effects on the 
hypothalamic-pituitary axis, and resolution of uremia [11, 
Figure 3A. Gross image of resected right breast mass which 
measured 11.5 cm by 11 cm by 7 cm. Image courtesy of Dr. 
Eva Patalas, Cambridge Health Alliance, Dept of Radiology, 
Cambridge, MA
Figure 3B. Gross image of resected left breast mass which 
measured 10 cm by 10 cm by 7 cm. Image courtesy of Dr. 
Eva Patalas, Cambridge Health Alliance, Dept of Radiology, 
Cambridge, MA.
15]. Though a well-recognized side effect of cyclosporine 
A is increased incidence of malignancy, the incidence of 
de novo breast cancer in women who are chronically im-
munosuppressed following transplant is lower than that of 
the general population, and thus development of fibroad-
enomas in association with cyclosporine A therapy should 
not raise increased concern for malignancy [1]. Resolu-
tion of the fibroadenomas upon cessation of cyclosporine 
A therapy has been observed in one case, however more 
commonly the breast masses persist unchanged in size or 
appearance.
 The management of a giant fibroadenoma differs from 
that of a phyllodes tumor. Typical surgical intervention for 
a fibroadenoma is enucleation, while excision with wide 
margins is the standard of care for a phyllodes tumor [16]. 
However, there is no definitive means of distinguishing 
between these two possible diagnoses without pathologic 
examination of the entire specimen. Thus, surgeons are left 
with a conundrum: a decision regarding surgical approach 
must be made prior to the ascertainment of the diagnosis 
on which such a decision should be predicated. Specifi-
cally, neither fine-needle aspiration (FNA) nor core biopsy 
has been proven efficacious in the definitive diagnosis of 
a phyllodes tumor, since the microscopic heterogeneity 
of both lesions introduces significant sampling error to 
these more conservative diagnostic approaches. Cytological 
features of specimens from FNA biopsy, such as hypercel-
lular stromal fragments, can be present in both phyllodes 
tumors and fibroadenomas. Multinucleated stromal giant 
cells are less common in fibroadenomas than phyllodes 
tumors but considered non-specific and cannot be used as 
a diagnostic criterion [16]. Histologic features of a sample 
garnered from core needle biopsy similarly can be inter-
preted as consistent with either a phyllodes tumor or a 
fibroadenoma.
 In the presented case, both fine-needle aspiration and 
core needle biopsy were foregone because of the known di-
agnostic limitations noted above. Rather, an intraoperative 
decision to enucleate the masses was made following as-
sessment of the size of the lesions and the lack of adequate 
surrounding tissue margins. It was anticipated that if the 
specimens were found to be malignant, the patient would 
be brought back to the operating room for a complete 
bilaterally mastectomy.
 It is the combination of meticulous history taking, an 
attentive physical exam, a thorough imaging survey, and 
microscopic pathological examination, which will allow 
for tailored and definitive care to be delivered to adoles-
cent women presenting with large breast masses. In this 
young age group, avoiding overly invasive diagnostic and 
management practices is particularly important. It is the 
duty of those clinicians caring for such women to strive to 
address this chief complaint in a manner sensitive to the 
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Figure 4A. Low-power histologic examination of the right 
breast mass reveals a well-demarcated lesion character-
ized by fibroepithelial proliferation. Image courtesy of Dr. 
Eva Patalas, Cambridge Health Alliance, Dept of Radiology, 
Cambridge, MA.
Figure 4B. High-powered photomicrograph of the same 
mass shows elongated, compressed ducts (black arrows) 
as well as some dilated ducts (white arrows). Note the 
lack of architectural features typical of a pericanalicular or 
intracanalicular fibroadenoma, leading to classification of 
this lesion as a fibroadenoma variant. Image courtesy of Dr. 
Eva Patalas, Cambridge Health Alliance, Dept of Radiology, 
Cambridge, MA.
needs and concerns of this demographic. Knowledge of 
the limitations of traditional diagnostic modalities such as 
fine-needle aspiration and core-needle biopsy contributes 
to the ability to deliver such sensitive care. This case serves 
as an excellent example of a scenario in which the use of 
multiple radiologic modalities, coupled with a thorough 
clinical exam, allowed for elimination of unnecessary 
procedures in favor of the most direct surgical intervention 
with minimal delay. While fine-needle aspiration could 
have been performed, the results of this procedure would 
not have been definitive. Core needle biopsy would have 
carried significant risk of bleeding, as demonstrated by the 
substantial vascular structures encompassing the breast 
masses, and similarly would have been of limited diagnos-
tic value. In this case, expediant and definitive care was 
delivered through the proper integration of clinical and 
radiologic findings and the application of these findings to 
the development of a rational, individually tailored, and 
ultimately curative surgical intervention.
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